- Home
- BURL vs MRNA Comparison
BURL vs MRNA Comparison
Compare BURL & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BURL | MRNA |
|---|---|---|
| Founded | 1972 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.6B | 19.7B |
| IPO Year | 2013 | 2018 |
Fundamental Metrics
Financial Performance| Metric | BURL | MRNA |
|---|---|---|
| Price | $338.21 | $53.22 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 16 | 12 |
| Target Price | ★ $355.29 | $34.27 |
| AVG Volume (30 Days) | 669.1K | ★ 5.2M |
| Earning Date | 05-28-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 21.92 | 21.77 |
| EPS | ★ 9.51 | N/A |
| Revenue | $11,566,910,000.00 | ★ $19,263,000,000.00 |
| Revenue This Year | $12.81 | $8.74 |
| Revenue Next Year | $8.44 | $16.18 |
| P/E Ratio | $35.81 | ★ N/A |
| Revenue Growth | ★ 8.76 | 4.29 |
| 52 Week Low | $212.92 | $22.28 |
| 52 Week High | $342.97 | $59.55 |
Technical Indicators
Market Signals| Indicator | BURL | MRNA |
|---|---|---|
| Relative Strength Index (RSI) | 60.48 | 56.23 |
| Support Level | $290.22 | $47.61 |
| Resistance Level | N/A | $54.94 |
| Average True Range (ATR) | 9.16 | 2.54 |
| MACD | 0.62 | 0.20 |
| Stochastic Oscillator | 87.39 | 75.81 |
Price Performance
Historical ComparisonAbout BURL Burlington Stores Inc.
Burlington Stores Inc is off-price retailer offering an extensive selection of in-season, fashion-focused merchandise including: women's ready-to-wear apparel, menswear, youth apparel, baby, beauty, footwear, accessories, home, toys, gifts and coats. Company sell a broad selection of desirable, first-quality, current-brand, labeled merchandise acquired directly from nationally recognized manufacturers and other suppliers. Company sell product in category such as Ladies apparel, Accessories and shoes, Home, Mens apparel, Kids apparel and baby and Outerwear.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.